Patent · US Active

Human gut microbiome-derived biosynthetic enzymes for production of fatty acid amides

US11441162B2 · kind B2 · utility

0Cited by

0References

31Claims

0Family size

Assignee

Massachusetts Institute of Technology · US

Inventors

Christopher A. Voigt · Oakland, US
Fang-Yuan Chang · Somerville, US

Key dates

Filing date	Mar 6, 2020
Grant date	Sep 13, 2022
Priority date	—
Expiry date	Mar 13, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Y602/0102
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Disclosed herein, in some embodiments, are vectors encoding biosynthetic enzymes from gut microbiome-derived bacterium (e.g., Clostridia enzymes), engineered cells comprising the vectors, and methods of using biosynthetic enzymes from gut microbiome-derived bacterium (e.g., Clostridia enzymes) to produce fatty acid amides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.